Refine by
Innovative Validated Healthcare Articles & Analysis: Older
137 news found
Bedfont® Scientific Ltd., world leaders in breath analysis with over 47 years of knowledge in designing and manufacturing medical breath analysis devices, welcomes the recent update to the National Institute for Health and Care Excellence (NICE) guidelines on asthma management. Bedfont® manufactures the NObreath® Fractional exhaled Nitric Oxide (FeNO) device, which aids in diagnosing ...
This novel dosage form ensures rapid absorption and high bioavailability, meeting the urgent needs of modern healthcare. The company’s broad range of services includes initial formulation development, process optimization, large-scale production, and packaging. ...
US-based MedSource Labs and Sydney’s Medilogic enter into an exclusive, strategic partnership in the peripheral safety IV market with the announcement of Logiflow Exactus and Logiflow Exactus Shield with Blood Control IV Catheters with active blood control check valve technology in ...
Investorideas.com (www.investorideas.com) Biotech Stock News Bites - Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines is one of NASDAQ's top gainers today and the stock is trending on Yahoo Finance, currently trading at $3.8955, up $1.6955 or 77.0682%. The stock had a morning high of $5.47 on volume of over 36 Million/. The Company's CEO, ...
Founded in 1963, in Maids Moreton, Vitalograph’s mission has remained unwavering over the past six decades – to improve the lives of people living with lung conditions through the development and manufacture of respiratory diagnostic solutions. As experts in pulmonary function, they also provide clinical drug trial services that enable the development of life-changing respiratory ...
In the world of healthcare and innovation, where the qualitative and financial pressures are high and the challenges are complex, there exists a unique and exclusive gathering that is working to revolutionize the future of surgery. They are the Caresyntax Future of Surgery Dinners, and they are a unique format for bringing together leaders of health systems, med tech, surgery, insurance, and ...
Canaquest Medical Corp (OTC:CANQF) (the "Company" or "CanaQuest"), a clinical-stage life sciences company focused on drug discovery and development of next-generation targeted cannabinoid therapeutics for the central nervous system (CNS), today announced the signing of a Master Service Agreement with Neeka Health (“Neeka”) that will encompass multiple clinical studies to evaluate the ...
Dr. Ali Tinazli's post at the Forbes magazine about "History Of Health Technologies And Meaningful Change In The Era Of Health 4.0" The medicine in ancient Egypt is some of the oldest in history. Although rudimentary, it was already highly personalized and with exclusive access. During the Renaissance—one of the most remarkable ages of humankind—medicine ...
Additionally, the designation validates our belief in the potential of our stem cell regenerative PEDF-Derived Short Peptide (PDSP), which underpins several products in our pipeline, and has the potential to be effective in multiple therapy areas and ...
“This is a tremendous opportunity to be a part of a smart and talented team creating real impact in healthcare,” said Frederick. “I’m delighted to join a mission-driven company on the forefront of innovation, democratizing safer, better surgical procedures through groundbreaking virtual reality ...
Oncology informatics company, Inspirata, is pleased to announce the recent addition of a new key member to the company’s leadership team. Effective November 17, 2022, Laure Tessier-Delivuk, PMP, has joined as Vice President of Operations – Oncology Informatics. Laure brings 25+ years of experience as a Healthcare Technology executive leader and a proven track record in managing ...
BioIntelliSense, a continuous health monitoring and clinical intelligence company, today announced its partnership with the Translational Research Institute for Space Health (TRISH) to further understanding of human health in space. The BioButton® medical grade wearable device will be used for commercial spaceflight research programs and notably during the upcoming five-day Polaris Dawn ...
During the commissioning process, the Helsinki nuBeam® device has demonstrated both robustness and reliable operation, validating Neutron Therapeutics’ technology as the best choice for high-throughput BNCT clinics with stringent safety requirements. ...
Today, the Baker-Polito Administration announced that more than $1.5 million has been awarded to four projects that seek to increase testing capacity and provide solutions for coronavirus testing. The funding is through the Accelerating Coronavirus Testing Solutions (A.C.T.S.) Program, designed and administered by the Massachusetts Life Sciences Center, which supports projects focused on two core ...
T-Control received an extremely positive feedback at HealthIO Global 2018, one of the most important events in Europe in the medical innovation field. It brings together patients, healthcare professionals and innovators in order to understand each other´s needs and find innovative solutions. T-Control was specially appreciated by nurses who clearly see the advantages it can offer them and ...
Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical stage biotechnology company powering continuous delivery of approved drugs in novel indications, announced today the appointment of Moses Dodo to its Board of Directors. “We are thrilled to welcome Moses to our Board; as an Independent Director Moses brings valuable reimbursement, banking and ...
“The more quality data we get from world-class institutions validating the effectiveness of our technology, the better we can innovate our offerings to support and inspire the next generation of healthcare professionals,” said Andrea Zider, Senior Director of Medical Affairs at Osso VR. ...
25 European companies from the Biotech, Medtech, Innovative Services & Digital Health sectors, committed to patients, selected by the European clusters, will present their innovation to a jury composed of HTFC’s sponsors and the HTID health innovation ecosystem. The HealthTech Innovation Days (HTID®) event, organized by the HealthTech For Care (HTFC) endowment fund, is launching ...
BioSerenity, a high-growth company specializing in research and remote diagnostic solutions for neurology, sleep medicine, and cardiology, announces Jeff Wren’s appointment as Chief Executive Officer of North America. Jeff Wren assumes the leadership role in the states as Pierre Frouin, CEO of BioSerenity, moves back to Europe. Since its expansion to the United States in 2019, ...
CORALVILLE, IOWA July 26, 2022 – Digital Diagnostics is proud to announce a partnership with ArchWell Health to bring IDx-DR, the autonomous AI diagnostic system for the detection of diabetic retinopathy (DR) – including diabetic macular edema (DME) – to ArchWell Health centers across the United States. “ArchWell Health is committed to improving patient outcomes and ...